financetom
Business
financetom
/
Business
/
1911 Gold Confirms Resource Continuity in Underground Infill and Delineation Drilling at True North
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
1911 Gold Confirms Resource Continuity in Underground Infill and Delineation Drilling at True North
Mar 11, 2026 7:29 AM

09:44 AM EDT, 03/11/2026 (MT Newswires) -- 1911 Gold ( AUMBF ) on Wednesday said drilling results from the underground drill program at its wholly-owned operational and fully permitted True North Gold project, located in southeast Manitoba, Canada, confirmed the continuity of gold (Au) mineralization

In a statement it said this was within the mineral resources outlined in the Preliminary Economic Assessment mine plan for the early years of mining on the V-810 vein within the Hinge Zone, and the V-1030/V-1040 vein within the L10 Zone, both located adjacent to Level 16 of True North.

"The drilling at Hinge and L10 not only confirms the continuity of gold mineralization in these veins but also demonstrates that these zones are wider on average than previously modelled," said Chief Executive Shaun Heinrichs. "The ongoing drill program is focussed on infill and delineation drilling in areas that are included in the first years of mining within the PEA mine plan and support the bulk sample and test mining activities scheduled for later this year."

The company said current development drilling continues to focus on upgrading and delineating the resources for the initial years of the mine schedule and supporting the upcoming bulk sampling and test mining activities.

Shares of the company were last seen down more than 4% on Wednesday, having closed up 6.1% on Tuesday on the TSX Venture Exchange.

Price: 1.18, Change: -0.03, Percent Change: -2.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fuel cell maker Ballard Power Q3 revenue beats estimates on higher deliveries
Fuel cell maker Ballard Power Q3 revenue beats estimates on higher deliveries
Nov 13, 2025
Overview * Ballard Q3 2025 revenue up 120% YoY to $32.5 mln, beating analyst expectations * Gross margin improved to 15%, a 71-point increase YoY * Company reduced operating expenses by 36% due to restructuring Outlook * Company revises 2025 capital expenditure guidance to $8-$12 mln from $15-$25 mln * Ballard expects 2025 operating expenses to be below lower end...
Stratasys Q3 revenue of $137 mln beats analyst expectations
Stratasys Q3 revenue of $137 mln beats analyst expectations
Nov 13, 2025
Overview * Stratasys ( SSYS ) Q3 revenue of $137 mln beats analyst expectations * Adjusted EPS of $0.02 beats analyst estimates * Company reports GAAP net loss due to $33.9 mln non-cash impairment Outlook * Stratasys ( SSYS ) sees full-year revenue between $550 mln and $560 mln * Company expects full-year non-GAAP gross margins of 46.7% to 47.0%...
Suburban Propane Q4 net loss narrows on higher demand, margin management
Suburban Propane Q4 net loss narrows on higher demand, margin management
Nov 13, 2025
Overview * Suburban Propane ( SPH ) Q4 net loss narrows to $35.1 mln from $44.6 mln last year * Adjusted EBITDA for Q4 slightly down from last year * Retail propane gallons sold in Q4 increased 1.8% yr/yr Outlook * Company did not provide specific guidance for future periods Result Drivers * INCREASED PROPANE DEMAND - Strong propane demand...
Clinic operator NeuPath's Q3 revenue beats on fluoroscopy demand
Clinic operator NeuPath's Q3 revenue beats on fluoroscopy demand
Nov 13, 2025
Overview * NeuPath Q3 revenue rises 26% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 up 98% yr/yr, marking 27th consecutive positive quarter * Company attributes growth to optimized clinic footprint and increased patient treatment time Outlook * NeuPath expects continued organic and inorganic growth for the balance of 2025 and beyond * Company anticipates strong demand for Arthrosamid...
Copyright 2023-2026 - www.financetom.com All Rights Reserved